ENVB
Enveric BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ENVB vs peer average
75/100
ENVB vs. peer average (B vs. D)
Grade spread
A 1 · B 2 · C 2 · D 2 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AKAN is the first available peer comparator.
Loose same-sector micro-cap screen candidate; no direct mechanistic, indication, or clinical comparability is established. Exclude from valuation benchmarking.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ENVB
Enveric Biosciences
AKAN
Akanda
Grade
B
B
Momentum
97
1
Value
58
46
Sentiment
48
84
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs AKAN
ENVB / AKAN
Grade Position
Above peers
ENVB vs. peer average (B vs. D)
75/100
Momentum
97
ENVBValue
58
ENVBSentiment
48
AKANRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ENVB
AKAN is the first peer returned for this comparison set.